Nadia Harbeck
MD, PhD
Professor and Head, Breast Center
👥Biography 个人简介
Prof. Nadia Harbeck is head of the breast center at LMU Munich and a leading expert in breast cancer perioperative treatment. She was among the principal investigators of KEYNOTE-522, the pivotal trial establishing neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab for triple-negative breast cancer. Her work has defined pCR as a validated surrogate endpoint for event-free survival in TNBC.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Nadia Harbeck 的研究动态
Follow Nadia Harbeck's research updates
留下邮箱，当我们发布与 Nadia Harbeck（Ludwig Maximilian University Munich）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment